ARFGEF2 Gene Periventricular heterotopia with microcephaly Genetic Test
The ARFGEF2 gene is associated with a condition called periventricular heterotopia with microcephaly. Periventricular heterotopia is a brain malformation characterized by the presence of nodules of gray matter located along the lateral ventricles, instead of being properly positioned within the cerebral cortex. Microcephaly refers to a smaller than average head size.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify mutations or variations that may be associated with a particular condition. In the case of periventricular heterotopia with microcephaly, NGS genetic testing can be used to examine the ARFGEF2 gene for any mutations or variations that may be causing the condition.
This type of genetic testing can provide valuable information for diagnosing individuals with periventricular heterotopia with microcephaly and can also help determine the mode of inheritance, provide information for genetic counseling, and potentially guide treatment options. It is typically performed by obtaining a blood or saliva sample from the individual being tested and analyzing the DNA for any genetic abnormalities in the ARFGEF2 gene.
Test Details
- Test Name: ARFGEF2 Gene Periventricular heterotopia with microcephaly Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for ARFGEF2 Gene Periventricular heterotopia with microcephaly NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ARFGEF2 Gene Periventricular heterotopia with microcephaly.
Test Process
The test involves obtaining a blood or saliva sample from the individual being tested. The sample is then analyzed using NGS technology to examine the ARFGEF2 gene for any mutations or variations that may be causing periventricular heterotopia with microcephaly. The test results are typically delivered within 3 to 4 weeks.
Conclusion
The ARFGEF2 Gene Periventricular heterotopia with microcephaly Genetic Test is a valuable tool for diagnosing individuals with periventricular heterotopia with microcephaly. It can provide important information for genetic counseling, determining the mode of inheritance, and guiding treatment options. The test is performed by analyzing a blood or saliva sample using NGS technology. The cost of the test is 4400.0 AED.
Test Name | ARFGEF2 Gene Periventricular heterotopia with microcephaly Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ARFGEF2 Gene Periventricular heterotopia with microcephaly NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ARFGEF2 Gene Periventricular heterotopia with microcephaly |
Test Details |
The ARFGEF2 gene is associated with a condition called periventricular heterotopia with microcephaly. Periventricular heterotopia is a brain malformation characterized by the presence of nodules of gray matter located along the lateral ventricles, instead of being properly positioned within the cerebral cortex. Microcephaly refers to a smaller than average head size. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify mutations or variations that may be associated with a particular condition. In the case of periventricular heterotopia with microcephaly, NGS genetic testing can be used to examine the ARFGEF2 gene for any mutations or variations that may be causing the condition. This type of genetic testing can provide valuable information for diagnosing individuals with periventricular heterotopia with microcephaly and can also help determine the mode of inheritance, provide information for genetic counseling, and potentially guide treatment options. It is typically performed by obtaining a blood or saliva sample from the individual being tested and analyzing the DNA for any genetic abnormalities in the ARFGEF2 gene. |